Literature DB >> 12566703

Virus-like particles as a modular system for novel vaccines.

Franziska Lechner1, Andrea Jegerlehner, Alain C Tissot, Patrik Maurer, Peter Sebbel, Wolfgang A Renner, Gary T Jennings, Martin F Bachmann.   

Abstract

Induction of protective immune responses with recombinant antigens is a major challenge for the vaccine industry. Here we present a molecular assembly system that renders antigens of choice highly repetitive. Using this method, efficient antibody responses may be induced in the absence of adjuvants resulting in protection from viral infection and allergic reactions. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12566703     DOI: 10.1159/000067912

Source DB:  PubMed          Journal:  Intervirology        ISSN: 0300-5526            Impact factor:   1.763


  17 in total

1.  Virus-like particle vaccine activates conventional B2 cells and promotes B cell differentiation to IgG2a producing plasma cells.

Authors:  Sheng Zhang; Rafael Cubas; Min Li; Changyi Chen; Qizhi Yao
Journal:  Mol Immunol       Date:  2009-04-18       Impact factor: 4.407

Review 2.  Success and failure of vaccines against renin-angiotensin system components.

Authors:  Morris J Brown
Journal:  Nat Rev Cardiol       Date:  2009-08-25       Impact factor: 32.419

Review 3.  Plant-derived virus-like particles as vaccines.

Authors:  Qiang Chen; Huafang Lai
Journal:  Hum Vaccin Immunother       Date:  2012-09-20       Impact factor: 3.452

Review 4.  Virus-like particles as antigenic nanomaterials for inducing protective immune responses in the lung.

Authors:  Agnieszka Rynda-Apple; Dustin P Patterson; Trevor Douglas
Journal:  Nanomedicine (Lond)       Date:  2014       Impact factor: 5.307

5.  Displaying Fel d1 on virus-like particles prevents reactogenicity despite greatly enhanced immunogenicity: a novel therapy for cat allergy.

Authors:  Nicole Schmitz; Klaus Dietmeier; Monika Bauer; Melanie Maudrich; Stefan Utzinger; Simone Muntwiler; Philippe Saudan; Martin F Bachmann
Journal:  J Exp Med       Date:  2009-08-10       Impact factor: 14.307

Review 6.  Obesity vaccines.

Authors:  Mariana P Monteiro
Journal:  Hum Vaccin Immunother       Date:  2013-12-23       Impact factor: 3.452

7.  Self-Antigens Displayed on Liposomal Nanoparticles above a Threshold of Epitope Density Elicit Class-Switched Autoreactive Antibodies Independent of T Cell Help.

Authors:  Zhilin Chen; Wei-Yun Wholey; Alireza Hassani Najafabadi; James J Moon; Irina Grigorova; Bryce Chackerian; Wei Cheng
Journal:  J Immunol       Date:  2019-12-13       Impact factor: 5.422

Review 8.  Fluorosomes: fluorescent virus-like nanoparticles that represent a convenient tool to visualize receptor-ligand interactions.

Authors:  Daniela Wojta-Stremayr; Winfried F Pickl
Journal:  Sensors (Basel)       Date:  2013-07-08       Impact factor: 3.576

9.  Immunization against active ghrelin using virus-like particles for obesity treatment.

Authors:  Sara Andrade; Filipa Pinho; Andreia M Ribeiro; Marcos Carreira; Felipe F Casanueva; Polly Roy; Mariana P Monteiro
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

10.  A Novel Virus-Like Particle Based Vaccine Platform Displaying the Placental Malaria Antigen VAR2CSA.

Authors:  Susan Thrane; Christoph M Janitzek; Mette Ø Agerbæk; Sisse B Ditlev; Mafalda Resende; Morten A Nielsen; Thor G Theander; Ali Salanti; Adam F Sander
Journal:  PLoS One       Date:  2015-11-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.